Cargando…
Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis
BACKGROUND: The evidence has shown that SARS CoV-2 infected patients with comorbidities are more likely to have severe disease sequel and mortality. In SARS-CoV-2 infected cancer patients risks associated with other underlying comorbidities might vary from those in non-cancer SARS CoV-2 infected pat...
Autores principales: | Kaur, Harmanjeet, Thakur, JS, Paika, Ronika, Advani, Shailesh M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408376/ https://www.ncbi.nlm.nih.gov/pubmed/34048161 http://dx.doi.org/10.31557/APJCP.2021.22.5.1333 |
Ejemplares similares
-
Determinants of smokeless tobacco use in India
por: Thakur, J.S., et al.
Publicado: (2018) -
Effectiveness of targeting the health promotion settings for non-communicable disease control in low/middle-income countries: systematic review protocol
por: Jeet, Gursimer, et al.
Publicado: (2018) -
Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis
por: Alkhathami, Mohammed G., et al.
Publicado: (2021) -
The Impact of Charlson Comorbidity Index on Mortality From SARS-CoV-2 Virus Infection
por: Ahmed, Jawad, et al.
Publicado: (2021) -
Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis
por: Espinosa, Omar Ariel, et al.
Publicado: (2020)